A clinical trial is a study conducted with actual patients, usually to evaluate a new treatment. Each study is designed to answer scientific questions and to find new and better ways to help patients.
Official study title: Effect of microablative CO2 laser therapy on the vaginal and urinary bacterial and fungal microbiota of postmenopausal women with genitourinary syndrome of menopause
Description: The purpose of this study is to confirm and better understand the effects of microablative CO2 laser therapy in treating symptoms and signs of genitourinary symptoms of menopause “GSM” and to study the effects of this treatment on the bacteria and fungi found in the bladder and vagina. We plan to accomplish this by asking women who have already chosen vaginal laser therapy as a clinical treatment for their GSM symptoms.
Basic information: Patients will receive laser therapy according to standard procedure for this treatment, receiving three treatments spaced 6 weeks apart, and follow-up appointments at 6 and 12 months. Patients will receive an exam, swabs, and be asked to take surveys. Patients must meet the following criteria:
For more information, visit UCLA Health Clinical Trials.
Principal Investigator:
Chad Z. Baxter, MD
Assistant Clinical Professor of UCLA Urology
Contact Information:
Email: [email protected]
Tel: 310-267-4331
Official Study Title: Medtronic Evaluation of InterStim Micro System Performance And Safety (ELITE) to Confirm Long-Term Outcomes
Description: The purpose of this study is to gather long-term information on the use of the InterStim Micro System.
The information from this study will be used to:
Symptoms of overactive bladder include an increased urge to urinate which may lead to unconscious leakage of urine and/or a frequent urination, symptoms of fecal incontinence include the inability to control bowel movements and symptoms for non-obstructive urinary retention include the inability to urinate.
The InterStim Micro System mentioned above is approved by the U.S. Food and Drug Administration (FDA), for patients who have overactive bladder, fecal incontinence and/or non-obstructive urinary retention. InterStim Therapy is for subjects for whom less invasive treatments have not worked.
Basic Information: We expect that participants will be in this research study for about 2 years.
Patients will have two surgeries to implant the InterStim Micro System and will be asked to come in for 7 study visits. You will be asked to fill out bladder and/or bowel diaries and questionnaires.
Patients must meet the following criteria:
For more information, visit UCLA Health Clinical Trials.
Principal Investigator:
Victor Nitti, MD
Professor of Urology and Obstetrics and Gynecology
Chief of Female Pelvic Medicine and Reconstructive Surgery (FPMRS)
Contact Information:
Email: [email protected]
Tel: 310-267-4331
